XML 42 R73.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Derivatives (Cash Flow Hedging Instruments) (Details) (USD $)
In Thousands
12 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2009
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) $ (34,821) $ (652) $ 5,186
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 12 6 (6)
Gain (Loss) from Amounts Excluded from Effectiveness Testing (315) (212) (1,231)
Gain/(Loss) Recognized in OCI (Effective Portion) (82,270) 26,984 (8,021)
Foreign Exchange Contracts [Member]
     
Gain/(Loss) Recognized in OCI (Effective Portion) (82,165) 27,967 (5,355)
Foreign Exchange Contracts [Member] | Other Expense [Member]
     
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) 0 0 0
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 0 0 0
Gain (Loss) from Amounts Excluded from Effectiveness Testing 0 0 (1,160)
Gains and losses from derivative instruments that are not designated as hedging instruments (1,938) 3,357 0
Foreign Exchange Contracts [Member] | Cost Of Sales [Member]
     
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) (34,063) (2,028) 4,890
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 0 0 0
Gain (Loss) from Amounts Excluded from Effectiveness Testing 15 19 0
Gains and losses from derivative instruments that are not designated as hedging instruments (260) 311 (287)
Foreign Exchange Contracts [Member] | SG&A [Member]
     
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) 0 2,203 347
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 21 14 0
Gain (Loss) from Amounts Excluded from Effectiveness Testing (330) (231) (71)
Interest Rate Swap [Member]
     
Gain/(Loss) Recognized in OCI (Effective Portion) (105) (983) (2,666)
Interest Rate Swap [Member] | Rent Expense [Member]
     
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) (758) (827) (51)
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) (9) (8) (6)
Gain (Loss) from Amounts Excluded from Effectiveness Testing $ 0 $ 0 $ 0